Literature DB >> 29459087

Identification of five Mitragyna alkaloids in urine using liquid chromatography-quadrupole/time of flight mass spectrometry.

Stephanie Basiliere1, Kelsie Bryand1, Sarah Kerrigan2.   

Abstract

Mitragyna speciosa (Kratom) is a psychoactive plant that has recently emerged as a recreational drug. Mitragyna alkaloids are not within the scope of traditional forensic toxicology screening methods, which may contribute to under-reporting. Solid phase extraction (SPE) and liquid chromatography-quadrupole/time of flight mass spectrometry (LC-Q/TOF-MS) were used to identify five alkaloids in urine. Target analytes included the two known psychoactive compounds, mitragynine and 7-hydroxymitragynine, in addition to speciociliatine, speciogynine, and paynantheine. Two deuterated internal standards (mitragynine-D3 and 7-hydroxymitragynine-D3) were employed. Using traditional reversed phase chromatography all compounds and isomers were separated in 10 min. The procedure was validated in accordance with the Scientific Working Group for Forensic Toxicology (SWGTOX) Standard Practices for Method Validation. Extraction efficiencies were 63-96% and limits of quantitation were 0.5-1 ng/mL. Precision, bias and matrix effects were all within acceptable thresholds, with the exception of 7-hydroxymitragynine, which is notably unstable and unsuitable for quantitative analysis. In this paper we present a simultaneous quantitative analytical method for mitragynine, speciociliatine, speciogynine and paynantheine, and a qualitative assay for 7-hydroxymitragynine in urine using high resolution mass spectrometry (HRMS).
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HRMS; Kratom; LC-Q/TOF-MS; Mitragynine; Urine

Mesh:

Substances:

Year:  2018        PMID: 29459087     DOI: 10.1016/j.jchromb.2018.02.010

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

Review 1.  Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples.

Authors:  Vânia Meireles; Tiago Rosado; Mário Barroso; Sofia Soares; Joana Gonçalves; Ângelo Luís; Débora Caramelo; Ana Y Simão; Nicolás Fernández; Ana Paula Duarte; Eugenia Gallardo
Journal:  Medicines (Basel)       Date:  2019-03-04

2.  The analysis of commercially available natural products recommended for use in electronic cigarettes.

Authors:  Michelle R Peace; Mika E Smith; Justin L Poklis
Journal:  Rapid Commun Mass Spectrom       Date:  2020-06-15       Impact factor: 2.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.